Menopause is associated with reduced protection from postprandial lipemia

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 11, 1999, Pages 2737-2741

  Van Beek, André P ^a,c   De Ruijter Heijstek, Florianne C ^a   Erkelens, D Willem ^a   De Bruin, Tjerk W A ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c Departments of Internal Medicine and Endocrinology F02124   (Netherlands)

Author keywords

Chylomicrons; Coronary heart disease; Estrogens; Lipids; Risk factors

Indexed keywords

CHOLESTEROL; CHYLOMICRON; ESTROGEN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RETINOL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; FEMALE; HUMAN; HYPERLIPIDEMIA; LIPID DIET; MENOPAUSE; MORTALITY; PREMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0032724238     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.11.2737     Document Type: Article

References (22)

1. Rosenberg L, Hennekens CH, Rosner B, Belanger C, Rothman KJ, Speizer FE. Early menopause and the risk of myocardial infarction. Am J Obstet Gynecol. 1981;139:47-51.
2. van der Schouw YT, van der Graaf Y, Steyerberg EW, Eijkemans JC, Banga JD. Age at menopause as a risk factor for cardiovascular mortality. Lancet. 1996;347:714-718.
3. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. N Engl J Med. 1987;316:1105-1110.
4. Stevenson JC, Crook D, Godsland IF. Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis. 1993;98:83-90.
5. Matthews KA, Meilahn E, Kuller LH, Kelsey SF, Caggiula AW, Wing RR. Menopause and risk factors for coronary heart disease. N Engl J Med. 1989;321:641-646.
6. Bass KM, Newschaffer CJ, Klag MJ, Bush TL. Plasma lipoprotein levels as predictors of cardiovascular death in women. Arch Intern Med. 1993;153:2209-2216.
7. Kannel WB. Metabolic risk factors for coronary heart disease in women: perspective from the Framingham study. Am Heart J. 1987;114:413-419.
8. Austin MA. Plasma triglyceride and coronary heart disease. Arterioscler Thromb. 1991;11:2-14.
9. Groot PHE, Van Stiphout WAHJ, Krauss XH, Jansen H, van Tol A, Van Ramshorst E, Chin-On S, Hofman A, Creswell SR, Havekes L. Postprandial lipoprotein metabolism in normolipidimic men with and without coronary artery disease. Arterioscler Thromb. 1991;11:653-662.
10. Patsch JR, Miesenbock G, Hopferwieser T, Muhlberger V, Knapp E, Dunn JK, Gotto AM Jr, Patsch W. Relation of triglyceride metabolism and coronary artery disease: studies in the postprandial state. Arterioscler Thromb. 1992;12:1336-1345.
11. Weintraub MS, Grosskopf I, Rassin T, Miller H, Charach G, Rotmensch HH, Liron M, Rubinstein A, Laina A. Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: case control study over three years. BMJ. 1996;312:936-939.
12. Meyer E, Westerveld HE, De Ruijter-Heijstek FC, Van Greevenbroek MMJ, Rienks R, Van Rijn HJM, Erkelens DW, De Bruin TWA. Abnormal postprandial apolipoprotein B-48 and triglyceride responses in normolipidemic women with greater than 70% stenotic coronary artery disease: a case-control study. Atherosclerosis. 1996;124:221-235.
13. Karpe F, Steiner G, Uffelman K, Olivecrona T, Hamsten A. Postprandial lipoproteins and progression of coronary sclerosis. Atherosclerosis. 1994;106:83-97.
14. Grundy SM, Mok HY. Chylomicron clearance in normal and hyperlipidemic man. Metabolism. 1976;25:1225-1239.
15. Weintraub MS, Eisenberg S, Breslow JL. Different patterns of postprandial lipoprotein metabolism in normal and type IIa, type III and type IV hyperlipoproteinemics: effects of treatment with cholestyramine and gemfibrozil. J Clin Invest. 1987;79:1110-1119.
16. Westerveld HT, Kock LA, van Rijn HJ, Erkelens DW, De Bruin TWA. 17β-Estradiol improves postprandial lipid metabolism in postmenopausal women. J Clin Endocrinol Metab. 1995;80:249-253.
17. Willett W, Stampfer MJ, Bain C, Lipnick R, Speizer FE, Rosner B, Cramer D, Hennekens CH. Cigarette smoking, relative weight, and menopause. Am J Epidemiol. 1983;117:651-658.
18. Crook D, Seed M. Endocrine control of plasma lipoprotein metabolism: effects of gonadal steroids. Baillieres Clin Endocrinol Metab. 1990;4:851-875.
19. Ginsberg J. What determines the age at the menopause? BMJ. 1991;302:1288-1289.
20. Jensen J, Nilas L, Christiansen C. Influence of menopause on serum lipids and lipoproteins. Maturitas. 1990;12:321-331.
21. Lindquist O, Bengtsson C. Serum lipids, arterial blood pressure and body weight in relation to the menopause: results from a population study of women in Goteborg, Sweden. Scand J Clin Lab Invest. 1980;40:629-636.
22. Brunzell JD, Hazzard WR, Porte D Jr, Bierman EL. Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man. J Clin Invest. 1973;52:1578-1585.